Essais liés3clinical trials
VilleNanchanglocalisation
PaysChinalocalisation
SourcelocaleCSV/MySQL

Informations

centre

Synchronisé depuis ClinicalTrials.gov — NCT06447597

Ouvrir le site du centre

Essais cliniques associés

3
MoléculeIndication / populationPhaseNCTTitreStatut
B007 Myasthénie Phase 2/3 NCT06447597 A Clinical Study of B007 in the Treatment of Generalized Myasthenia Gravis. RECRUITING
SG301 SC Injection Lupus Phase 1 NCT06144710 SG301-SC Injection Safety Study in Subjects With Systemic Lupus Erythematosus COMPLETED
RC18 160mg Myasthénie Phase 2 NCT04302103 A Study of TACI(Transmembrane Activator and Calcium-modulator and Cyclophilin Ligand (CAML) Interactor)-Antibody Fusion Protein Injection (RC18) in Subjects With Systemic Myasthenia Gravis COMPLETED